Roy Herbst

Type: Person

Name: Roy Herbst

First reported Jun 17 2013 - Updated Jun 17 2013 - 1 reports

Yourwellness Magazine Explores Cancer Research Innovations

According to a new study, presented at a news conference organised by the American Society of Clinical Oncology in advance of its annual meeting, which starts May 31st in Chicago, an experimental drug that taps the power of the body's immune system to ... [Published Digital Journal - Jun 17 2013]

Entities: Cancer Research, Cancer, Immune System, Tumor, Protein

First reported Jun 12 2013 - Updated Jun 12 2013 - 1 reports

6-12-2013 - Nature - ‘Master protocol’ aims to revamp cancer trials

Author:Heidi LedfordIn the push to match medical therapies to the genetic underpinnings of disease, lung-cancer treatments have been at the frontier. But the 1.6 million people diagnosed with this cancer every year will take scant comfort in knowing that ... [Published Friends of Cancer Research - Jun 12 2013]

Entities: cancer trials, Drugs, Clinical trials

First reported Jun 03 2013 - Updated Jun 03 2013 - 1 reports

American Society of Clinical Oncology

Treating refractory and metastatic lung cancer

CHICAGO – Dr. Roy Herbst of Yale University discusses early results for MPDL3280A, a new PD-L1 antibody for the treatment of non-small cell lung cancer; he also gives his take on other exciting lung cancer data being presented at the annual meeting of ... [Published Oncology Report - Jun 03 2013]

Entities: Lung Cancer, Metastatic, Roy Herbst, non-small cell lung cancer, American Society of Clinical Oncology

First reported May 31 2013 - Updated May 31 2013 - 1 reports

Raft of new drugs improve options for melanoma patients

FDA again expands options for those with skin cancer Becky Herry has tried nearly every drug available for melanoma.A few years ago, that would have been a very short list. Until recently, people with advanced melanoma often died within a year of diagnosis, ... [Published Delaware Online - May 31 2013]

Entities: Skin Cancer, Drugs, Patient

First reported May 29 2013 - Updated May 30 2013 - 1 reports

New drugs improve options for melanoma patients

Melanoma research will be in the spotlight at the annual meeting of the American Society of Clinical Oncology, which will begin Friday.(Photo: Andreas Dunker, AFP/)Story HighlightsMelanoma research is taking off, after decades of failuresNew drugs don't ... [Published USA Today - May 29 2013]

Entities: Skin Cancer, Drugs, Patient, Nivolumab

Quotes

"we have been very impressed by the response in seriously ill patients whose cancer had metastasized. so far, almost none of those who showed tumor shrinkage have gotten worse, which is extraordinary" said lead author Roy Herbst, M D , professor of medicine and chief of medical oncology at Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven...

Promising Drug Prevents Cancer Cells from Shutting Down Immu. . . [Published Equities.com - Jun 01 2013]

The findings mark the first clinical benefit of a small molecule targeted agent and standard chemotherapy in combination for lung cancer. "this study shows that an oral tyrosine kinase inhibitor can be combined with chemotherapy safely and effectively to provide systematic benefit to patients with this life-threatening disease. still, we need to build on this research and turn our focus toward better identifying molecular markers involved with the ultimate goal of personalizing our patient's care" said study's corresponding author Roy Herbst, professor and chief of the section of MD Anderson's Department of Thoracic/Head and Neck Medical Oncol...

Combination of Chemotherapy and Vandetanib may prove to be more effective for cancer [Published Topnews.in - Jun 07 2010]

More Content

sort by: Date \| Relevance
Yourwellness Magazine Explores Cancer Research ... [Published Digital Journal - Jun 17 2013]
6-12-2013 - Nature - ‘Master protocol’ aims to ... [Published Friends of Cancer Research - Jun 12 2013]
Metastatic tumors: New path in immunotherapy [Published Science Daily - Jun 04 2013]
Treating refractory and metastatic lung cancer [Published Oncology Report - Jun 03 2013]
Promising Drug Prevents Cancer Cells from Shutt... [Published Equities.com - Jun 01 2013]
Promising drug prevents cancer cells from shutt... [Published Health Canal - Jun 01 2013]
Raft of new drugs improve options for melanoma ... [Published Delaware Online - May 31 2013]
New drugs improve options for melanoma patients [Published News10Net - May 30 2013]
New drugs improve options for melanoma patients [Published USA Today - May 29 2013]
Combination of Chemotherapy and Vandetanib may ... [Published Topnews.in - Jun 07 2010]